Evidence map›Paper›PMID 42277209›Full record

ArticleActa pharmacologica Sinica2026

Amyloid-beta fibrils as active contributors to synaptic dysfunction in Alzheimer's disease.

Nunzia Maisto, Giorgia Ciufolini, Sepideh Dashtiani, Lorenzo Casoli, Almerinda Di Venere, Marilena Carbone, Dalila Mango

Abstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nunzia Maisto *School of Pharmacy, Department of Biology, University of Rome 'Tor Vergata', 00133, Rome, Italy.
Giorgia Ciufolini *Department of Chemical Science and Technologies, University of Rome 'Tor Vergata', 00133, Rome, Italy.
Sepideh DashtianiSchool of Pharmacy, Department of Biology, University of Rome 'Tor Vergata', 00133, Rome, Italy.
Lorenzo CasoliDepartment of Chemical Science and Technologies, University of Rome 'Tor Vergata', 00133, Rome, Italy.
Almerinda Di VenereDepartment of Experimental Medicine, University of Rome 'Tor Vergata', 00133, Rome, Italy.
Marilena CarboneDepartment of Chemical Science and Technologies, University of Rome 'Tor Vergata', 00133, Rome, Italy. carbone@uniroma2.it.
Dalila MangoSchool of Pharmacy, Department of Biology, University of Rome 'Tor Vergata', 00133, Rome, Italy. dalila.mango@uniroma2.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by the accumulation of amyloid-beta (Aβ) aggregates, in the form of fibrils and plaques. While it has largely been stated that Aβ oligomers are the main toxic species, significant evidence indicates that fibrils may also be relevant to AD pathogenesis. Notably, evidence indicates that while fibrils, through direct interaction with neuronal membranes, contribute to synaptic dysfunction and cellular damage, no direct evidence between fibrils and their impact on neuronal functions, including plasticity, was investigated. This study inquired into the impact of Aβ fibrils complex on neuronal function and membrane integrity, shedding light on their contribution to synaptic defects. Aβ fibrils were generated from Aβ

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesPeptide FragmentsSynapsesAnimalsFemaleHippocampusHumansMaleMiceMice, Inbred C57BLNeuronal PlasticityAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsAlzheimer’s diseaseAβ fibrilslipid-protein interactionneurotoxicitysynaptic plasticity

Identifiers

PMID42277209
PMCPMC13586234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.